Compare MDU & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDU | IDYA |
|---|---|---|
| Founded | 1924 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.6B |
| IPO Year | 1994 | 2019 |
| Metric | MDU | IDYA |
|---|---|---|
| Price | $18.63 | $31.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 16 |
| Target Price | $23.00 | ★ $51.54 |
| AVG Volume (30 Days) | ★ 1.5M | 986.4K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | N/A | ★ 61.90 |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $1,875,066,000.00 | $218,710,000.00 |
| Revenue This Year | $6.20 | N/A |
| Revenue Next Year | $7.01 | $216.42 |
| P/E Ratio | $40.45 | ★ N/A |
| Revenue Growth | 6.66 | ★ 3024.43 |
| 52 Week Low | $18.24 | $26.81 |
| 52 Week High | $22.98 | $42.68 |
| Indicator | MDU | IDYA |
|---|---|---|
| Relative Strength Index (RSI) | 41.00 | 33.78 |
| Support Level | $18.33 | $29.74 |
| Resistance Level | $18.94 | $35.44 |
| Average True Range (ATR) | 0.41 | 1.53 |
| MACD | -0.06 | -0.21 |
| Stochastic Oscillator | 26.30 | 4.75 |
MDU Resources Group Inc is a pure-play regulated energy delivery business. It is organized into three reportable business segments: Electric, Natural Gas Distribution, and Pipeline. Maximum revenue is generated from the Pipeline segment, which provides natural gas transportation and underground storage services through a FERC-regulated pipeline system mainly in the Rocky Mountain and northern Great Plains regions of the United States. This segment also provides non-regulated energy-related services, including cathodic protection. The electric segment generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming, and the natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.